Published in Chest on September 01, 1998
Guidelines for radiologically guided lung biopsy. Thorax (2003) 2.91
Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest (2012) 2.86
Variables affecting the risk of pneumothorax and intrapulmonal hemorrhage in CT-guided transthoracic biopsy. Eur Radiol (2008) 1.83
Trends in use and safety of image-guided transthoracic needle biopsies in patients with cancer. J Oncol Pract (2015) 1.45
Percutaneous transthoracic needle biopsy of small (≤ 1 cm) lung nodules under C-arm cone-beam CT virtual navigation guidance. Eur Radiol (2012) 1.09
Clinico-pathological profile of lung cancer in Uttarakhand. Lung India (2009) 1.07
Transthoracic needle biopsy of the lung. J Thorac Dis (2015) 0.93
Role of thoracic ultrasound in the assessment of pleural and pulmonary diseases. J Ultrasound (2008) 0.89
Does Repeating CT-Guided Transthoracic Fine Needle Aspiration Increase Diagnostic Yield and Complication Rate? A Single Institution Experience. Iran J Radiol (2013) 0.87
Computed tomography-guided fine needle aspiration cytology of solitary pulmonary nodules suspected to be bronchogenic carcinoma: Experience of a general hospital. J Cytol (2010) 0.83
Percutaneous biopsy in evaluation of lung nodules. JSLS (2004) 0.78
Evaluation of precision of guidance techniques in image guided fine needle aspiration cytology of thoracic mass lesions. J Cytol (2012) 0.78
Electromagnetic navigation transthoracic needle aspiration for the diagnosis of pulmonary nodules: a safety and feasibility pilot study. J Thorac Dis (2016) 0.76
Qualitative assessment of pain management in patients undergoing computed tomography-guided transthoracic lung biopsy. Pain Res Manag (2014) 0.75
CT-guided biopsy of pulmonary nodules: is pulmonary hemorrhage a complication or an advantage? Diagn Interv Radiol (2014) 0.75
Comparative study of bronchoalveolar lavage, bronchial brushing, and FNAC in diagnosing malignant neoplasms of lungs. J Cytol (2016) 0.75
Number of biopsies in diagnosing pulmonary nodules. Clin Med Insights Circ Respir Pulm Med (2010) 0.75
The role of ¹⁸F-FDG uptake features in the differential diagnosis of solitary pulmonary lesions with PET/CT. World J Surg Oncol (2015) 0.75
Is fine-needle aspiration diagnosis of malignancy adequate prior to major lung resections including pneumonectomy? Interact Cardiovasc Thorac Surg (2012) 0.75
Virtually no thoracic lesion inaccessible: a pictorial case review. Semin Intervent Radiol (2013) 0.75
THE MEASUREMENT OF SYMPATHETIC VASOCONSTRICTOR ACTIVITY IN THE LOWER EXTREMITIES. J Clin Invest (1930) 32.02
A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell (1991) 6.14
The heat resistance of bacterial spores at various water activities. J Gen Microbiol (1966) 4.23
Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science (1997) 2.59
A freely diffusible form of Sonic hedgehog mediates long-range signalling. Nature (2001) 2.50
Worldwide esophageal cancer collaboration. Dis Esophagus (2009) 2.41
Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice. Cancer Res (2000) 2.07
STUDIES ON THE ACTIVITY OF THE LUMBAR SYMPATHETIC NERVOUS SYSTEM. Ann Surg (1930) 1.83
Vascular endothelial growth factor as a marker of tumor endothelium. Cancer Res (1998) 1.78
Targeted disruption of the murine Nhe1 locus induces ataxia, growth retardation, and seizures. Am J Physiol (1999) 1.66
PUBLIC HEALTH ENGINEERING: SURVEY OF CONNECTICUT'S SHORE BATHING WATERS. Am J Public Health Nations Health (1932) 1.64
Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res (1995) 1.62
CHANGES IN THE VASOMOTOR REACTION ASSOCIATED WITH GLOMUS TUMORS. J Clin Invest (1937) 1.57
The preparation and cytotoxic properties of antibody-toxin conjugates. Immunol Rev (1982) 1.55
Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J Histochem Cytochem (2000) 1.41
Effects of various gases on the survival of dried bacteria during storage. Appl Microbiol (1973) 1.40
An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo. J Natl Cancer Inst (1985) 1.37
Preparation of antibody-toxin conjugates. Methods Enzymol (1985) 1.34
Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites. Cancer Res (2001) 1.34
Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. Cancer Res (2000) 1.25
Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan. Chest (1997) 1.25
Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways. Clin Cancer Res (2000) 1.19
An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins. Cancer Res (1988) 1.18
Fetal growth retardation in rats from different levels of hypoxia. Biol Neonate (1986) 1.16
Cytotoxicity acquired by conjugation of an anti-Thy1.1 monoclonal antibody and the ribosome-inactivating protein, gelonin. Eur J Biochem (1981) 1.15
A new method for radiochemical separation of arsenic from irradiated germanium oxide. Appl Radiat Isot (2005) 1.15
Toxicity of diphtheria toxin for lymphoblastoid cells is increased by conjugation to antilymphocytic globulin. Nature (1978) 1.14
1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors. Bioorg Med Chem Lett (2000) 1.14
Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells. J Immunol (1988) 1.10
Vascular targeting--a new approach to the therapy of solid tumors. Pharmacol Ther (1994) 1.08
Immunotoxins: magic bullets or misguided missiles? Immunol Today (1993) 1.08
Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixtures. Effects on toxicity and in vivo distribution. Eur J Biochem (1985) 1.07
Purification of ricin A1, A2, and B chains and characterization of their toxicity. J Biol Chem (1986) 1.06
Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc Natl Acad Sci U S A (1993) 1.06
Vascular endothelial growth factor and vascular targeting of solid tumors. Anticancer Res (2002) 1.05
Upper extremity venous thrombosis. Case report and literature review. Orthop Rev (1990) 1.05
Accelerated cytomegalovirus retinitis secondary to immunosuppressive therapy. Arch Ophthalmol (1986) 1.05
Potentiation of acetazolamide induced ectrodactyly in SWV and C57BL/6J mice by cadmium sulfate. Teratology (1984) 1.05
Standing surgical repair of cystorrhexis in two mares. Vet Surg (1999) 1.04
Ocular complications of Tangier disease. Am J Med (1987) 1.04
Expression of ricin A chain in Escherichia coli. FEBS Lett (1987) 1.03
The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications. Cancer (2001) 1.02
Microplate culture of mouse lymph node cells. I. Quantitation of responses to allogeneic lymphocytes endotoxin and phytomitogens. J Immunol Methods (1974) 1.02
THE QUANTITATIVE DETERMINATION OF VASOCONSTRICTOR SPASM AS A BASIS FOR THERAPY IN PERIPHERAL ARTERIAL DISEASES. Ann Surg (1932) 1.02
THE POSSIBILITY OF MALIGNANCY AS IT AFFECTS THE TREATMENT OF CHRONIC GASTRIC ULCER. Ann Surg (1935) 1.01
Legless, a novel mutation found in PHT1-1 transgenic mice. Science (1988) 1.00
A dynamic analysis of migration: an assessment of the effects of age, family and career variables. Demography (1981) 1.00
Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature. Cancer Res (1998) 0.99
The use of anti-ricin antibodies to protect mice intoxicated with ricin. Toxicology (1985) 0.99
Differential sensitivity of the SWV and C57BL/6 mouse strains to the teratogenic action of single administrations of cadmium given throughout the period of anterior neuropore closure. Teratology (1999) 0.99
The clinical correlates of a 3' truncating mutation (codons 1982-1983) in the adenomatous polyposis coli gene. Gastroenterology (1997) 0.98
Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions in vitro. Cancer Res (1991) 0.98
The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodies. Cell Immunol (1989) 0.97
SOME ANGIOSPASTIC SYNDROMES IN THE EXTREMITIES. Ann Surg (1931) 0.97
Purification of immunotoxins containing ricin A-chain and abrin A-chain using blue sepharose CL-6B. Anal Biochem (1987) 0.96
Expression of soluble VEGF receptor 2 and characterization of its binding by surface plasmon resonance. Biochem Biophys Res Commun (1998) 0.93
Developmental regulation and asymmetric expression of the gene encoding Cx43 gap junctions in the mouse limb bud. Dev Genet (1997) 0.93
The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis. J Pathol (2001) 0.93
Phenotypic characterization of the transgenic mouse insertional mutation, legless. J Exp Zool (1990) 0.93
Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibody. Cancer Res (1987) 0.91
Increased toxicity of diphtheria toxin for human lymphoblastoid cells following covalent linkage to anti-(human lymphocyte) globulin or its F(ab')2 fragment. Eur J Biochem (1980) 0.91
Cytotoxicity of a recombinant ricin-A-chain fusion protein containing a proteolytically-cleavable spacer sequence. FEBS Lett (1990) 0.90
Weak acids may act as teratogens by accumulating in the basic milieu of the early mammalian embryo. Nature (1986) 0.90
Immunotoxins: magic bullets or misguided missiles? Trends Pharmacol Sci (1993) 0.90
Effects of intrauterine administration of acetazolamide in rats. Teratology (1970) 0.89
Immunotoxins containing ricin or its A chain. Semin Cell Biol (1991) 0.89
PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis. Chest (1995) 0.89
The loss of ventral ectoderm identity correlates with the inability to form an AER in the legless hindlimb bud. Mech Dev (1998) 0.88
Selective cytotoxic activity of immunotoxins composed of a monoclonal anti-Thy 1.1 antibody and the ribosome-inactivating proteins bryodin and momordin. Br J Cancer (1988) 0.87
A murine model for antibody-directed targeting of vascular endothelial cells in solid tumors. Cancer Res (1992) 0.87
Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody-ricin conjugate. Nature (1982) 0.87
The removal of carbohydrates from ricin with endoglycosidases H, F and D and alpha-mannosidase. Biochim Biophys Acta (1985) 0.87
Comparative studies on acetazolamide teratogenesis in pregnant rats, rabbits, and rhesus monkeys. Teratology (1981) 0.87
Benign intracranial hypertension: a complication of subclavian vein catheterization and arteriovenous fistula. Am J Kidney Dis (1986) 0.87
VEGF-VEGF receptor complexes as markers of tumor vascular endothelium. J Control Release (2001) 0.86
Functional and morphological assessment of rat aorta stored in University of Wisconsin and Eurocollins solutions. Transplantation (1993) 0.86
Decreasing pH of rat embryos and fluids estimated by transplacental distribution of DMO. Am J Physiol (1989) 0.86
Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress. J Vasc Res (2004) 0.86
Endogenous electric current is associated with normal development of the vertebrate limb. Dev Dyn (2001) 0.85
Teratogenicity of di(2-ethylhexyl) phthalate, 2-ethylhexanol, 2-ethylhexanoic acid, and valproic acid, and potentiation by caffeine. Teratology (1987) 0.85
Hepatotoxicity of immunotoxins made with saporin, a ribosome-inactivating protein from Saponaria officinalis. Virchows Arch B Cell Pathol Incl Mol Pathol (1987) 0.85
DNA synthesis inhibition and cell death associated with hydroxyurea teratogenesis in rat embryos. Dev Biol (1971) 0.84
Dominant mutation of the murine Hox-2.2 gene results in developmental abnormalities. J Exp Zool (1992) 0.84
Intra-abdominal complications following prolonged cardiopulmonary resuscitation. Aust N Z J Surg (1993) 0.84
Characterization of the cell-surface procoagulant activity of T-lymphoblastoid cell lines. J Thromb Haemost (2004) 0.84
Phosphatidylserine exposure on the surface of Leishmania amazonensis amastigotes modulates in vivo infection and dendritic cell function. Parasite Immunol (2013) 0.84
Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells. Cancer Res (1988) 0.84
Teratogenicity of paraxanthine (1,7-dimethylxanthine) in C57BL/6J mice. Teratology (1986) 0.83
Emergence of immunoglobulin variants following treatment of a B cell leukemia with an immunotoxin composed of antiidiotypic antibody and saporin. J Exp Med (1987) 0.83
In vitro inhibition of endothelial cell growth by the antiangiogenic drug AGM-1470 (TNP-470) and the anti-endoglin antibody TEC-11. Anticancer Drugs (1997) 0.83
Blockade of the galactose-binding sites of ricin by its linkage to antibody. Specific cytotoxic effects of the conjugates. Eur J Biochem (1984) 0.83
Discovery of a new class of p38 kinase inhibitors. Bioorg Med Chem Lett (2000) 0.83
Preparation of 5-substituted 3-aminofuran-2-carboxylate esters. Org Lett (2000) 0.82
Determination of the proximate teratogen of the mouse fetal alcohol syndrome. 2. Pharmacokinetics of the placental transfer of ethanol and acetaldehyde. Toxicol Appl Pharmacol (1984) 0.82
Postnatal effects in rats of prenatal treatment with hydroxyurea. Teratology (1973) 0.82
The preparation of deglycosylated ricin by recombination of glycosidase-treated A- and B-chains: effects of deglycosylation on toxicity and in vivo distribution. Biochim Biophys Acta (1987) 0.82
Malformations in nonlimb structures induced by acetazolamide and other inhibitors of carbonic anhydrase. Ann N Y Acad Sci (1984) 0.82
Ethanol-induced limb defects in mice: effect of strain and Ro15-4513. Teratology (1990) 0.81
Low teratogenicity of 13-cis-retinoic acid (isotretinoin) in the mouse corresponds to low embryo concentrations during organogenesis: comparison to the all-trans isomer. Toxicol Appl Pharmacol (1987) 0.81
Weight differences in rat embryos prior to sexual differentiation. J Embryol Exp Morphol (1977) 0.81